Cargando…

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study

BACKGROUND: The efficacy of mitoxantrone induction therapy in rapidly worsening multiple sclerosis (MS) is well established. Plasma exchange is also applied as an adjuvant in exacerbations of relapsing MS. The aim of this study was to compare the efficacy of combination therapy with mitoxantrone and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabrizi, Nasim, Etemadifar, Masoud, Ashtari, Fereshteh, Zahed, Arash, Etemadifar, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697206/ https://www.ncbi.nlm.nih.gov/pubmed/23826008

Ejemplares similares

The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population
por: Abdar, Morteza, et al.
Publicado: (2016)

Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study
por: Etemadifar, Masoud, et al.
Publicado: (2011)

Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
por: Najafian, Jamshid, et al.
Publicado: (2019)

Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing–remitting multiple sclerosis patients and their family members
por: Samangooei, Mahsa, et al.
Publicado: (2022)

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial
por: Shaygannejad, Vahid, et al.
Publicado: (2012)

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
por: Doosti, Rozita, et al.
Publicado: (2021)

Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
por: Sedaghat, Nahad, et al.
Publicado: (2022)

Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial
por: Ashtari, Fereshteh, et al.
Publicado: (2011)

Conversion from Radiologically Isolated Syndrome to Multiple Sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2014)

Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial
por: Etemadifar, Masoud, et al.
Publicado: (2015)

Interleukin 18 Polymorphisms and its serum level in Patients with Multiple Sclerosis
por: Jahanbani-Ardakani, Hamidreza, et al.
Publicado: (2019)

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2018)

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Multiple sclerosis in Isfahan, Iran: Past, Present and Future
por: Etemadifar, Masoud, et al.
Publicado: (2012)

The role of information system in multiple sclerosis management
por: Ajami, Sima, et al.
Publicado: (2014)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases
por: Etemadifar, Masoud, et al.
Publicado: (2011)

Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data
por: Allizond, Valeria, et al.
Publicado: (2015)

Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis
por: Bansback*, Nick, et al.
Publicado: (2021)

Barriers to quality of life in patients with multiple sclerosis: a qualitative study
por: Hosseini, Zahra, et al.
Publicado: (2022)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis
por: Ebrahimi, Ali, et al.
Publicado: (2015)

Demographic features and clinical characteristics of patients with Parkinson’s disease in Isfahan, Iran
por: Salari, Mehri, et al.
Publicado: (2018)

Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis”
Publicado: (2021)

Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients
por: Hosseini, Aref, et al.
Publicado: (2016)

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
por: Yavari, Fatemeh, et al.
Publicado: (2021)

Clinical effectiveness and safety of fingolimod in relapsing remitting multiple sclerosis in Western Iran
por: Ouspid, Elham, et al.
Publicado: (2018)

Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis
por: Chitsaz, Ahmad, et al.
Publicado: (2013)

DNMT3B-579G>T (rs1569686G>T) polymorphism and the risk of multiple sclerosis in a subset of Iranian population
por: Yazdanpanahi, Nasrin, et al.
Publicado: (2019)

Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center
por: Bunganic, R., et al.
Publicado: (2022)

The relation between peptide hormones and sex hormone in patients with multiple sclerosis
por: Eftekhari, Elham, et al.
Publicado: (2013)

The effects of motivational interviewing on health promoting behaviors of patients with multiple sclerosis
por: Dashti, Alireza, et al.
Publicado: (2016)

A comparative study on iMed(©) and European database for multiple sclerosis to propose a common language of multiple sclerosis data elements
por: Ajami, Sima, et al.
Publicado: (2014)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8meakgfcul7ovpns2pvjpbcfu8